QIX Dividenden Europa
16 392,28
|
144,61
|
0,89 %
|
Analysen zu QIX Dividenden Europa-Werten
07.02.24 | Hannover Rück Buy | Jefferies & Company Inc. | |
07.02.24 | DHL Group Overweight | Barclays Capital | |
07.02.24 | Hannover Rück Overweight | JP Morgan Chase & Co. | |
07.02.24 | Hannover Rück Outperform | RBC Capital Markets | |
06.02.24 | Iberdrola Neutral | Goldman Sachs Group Inc. | |
06.02.24 | GSK Buy | UBS AG | |
06.02.24 | Hennes & Mauritz AB Neutral | UBS AG | |
05.02.24 | TotalEnergies Sector Perform | RBC Capital Markets | |
05.02.24 | GSK Buy | Deutsche Bank AG | |
05.02.24 | Roche Sell | Deutsche Bank AG | |
05.02.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
05.02.24 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.02.24 | Roche Neutral | UBS AG | |
02.02.24 | Hennes & Mauritz AB Neutral | UBS AG | |
02.02.24 | GSK Equal Weight | Barclays Capital | |
02.02.24 | Roche Kaufen | DZ BANK | |
02.02.24 | Roche Equal Weight | Barclays Capital | |
02.02.24 | Roche Sell | Deutsche Bank AG | |
02.02.24 | Siemens Buy | Deutsche Bank AG | |
02.02.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
02.02.24 | Mercedes-Benz Group Overweight | JP Morgan Chase & Co. | |
02.02.24 | Mercedes-Benz Group Outperform | Bernstein Research | |
01.02.24 | Hannover Rück Underweight | Barclays Capital | |
01.02.24 | GSK Halten | DZ BANK | |
01.02.24 | VINCI Buy | Jefferies & Company Inc. | |
01.02.24 | Roche Neutral | UBS AG | |
01.02.24 | Roche Underweight | JP Morgan Chase & Co. | |
01.02.24 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
01.02.24 | Hennes & Mauritz AB Sell | Deutsche Bank AG | |
01.02.24 | GSK Buy | Deutsche Bank AG | |
01.02.24 | GSK Buy | Deutsche Bank AG | |
01.02.24 | Roche Hold | Jefferies & Company Inc. | |
31.01.24 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
31.01.24 | Hennes & Mauritz AB Underperform | Bernstein Research | |
31.01.24 | Allianz Overweight | JP Morgan Chase & Co. | |
31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
31.01.24 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
31.01.24 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
31.01.24 | GSK Buy | UBS AG |